106017-08-7CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1.ClLPQOADBMXVRBNX-UHFFFAOYSA-N안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
개요Rufloxacin hydrochloride is another fluoroquinolone orally active antibacterial structurally and mechanistically related to temafloxacin and tosufloxacin. It is useful for the treatment of respiratory and urinary tract infections and also chronic bacterial prostatitis. Good tissue penetration with long acting activity has been reported.
용도Rufloxacin Hydrochloride inhibits human organic cation transporter 1 (hoCT1) (SLC22A1) but not hOCT2 (SLC22A2), and hOCT3 (SLC22A3) expressed in human embryonic kidney cell.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
106017-08-7DTXSID0045709CHEMBL1385206